Creative BioMart, a biotechnology company specializing in high-precision analytical and protein services, has recently updated its Radioimmunoassay (RIA) platform. This upgrade aims to provide researchers with more sensitive, accurate, and customizable tools for detecting and quantifying low-abundance analytes in a wide range of biological samples.

Radioimmunoassay is a highly sensitive immunoassay technique that combines the specificity of antibodies with the quantitative detection of radiolabeled tracers. Capable of measuring analytes at picogram levels, RIA remains a gold standard for applications where precision is critical—such as hormone profiling, drug monitoring, neuropeptide analysis, and biomarker validation. Its ability to handle diverse sample types makes it indispensable in endocrinology, oncology, pharmacology, and clinical research.

With the recent update, Creative BioMart now offers an expanded portfolio of RIA services, including:

l Broad analyte detection: Supports hormones, peptides, proteins, small molecules, and metabolites.

l Multiple isotope labeling options: Standard Iodine-125 tracers, with Tritium (^3H) and Carbon-14 available on request.

l Diverse sample compatibility: Processes serum, plasma, urine, tissue homogenates, and cell culture supernatants.

l Ultra-high sensitivity: Detection down to picogram per milliliter concentrations for trace-level quantitation.

l Flexible assay formats: Competitive binding, sandwich formats, or custom designs based on research needs.

l Custom assay development: Tailored solutions to meet specific project goals, including novel target validation.

l Rapid turnaround: Standard project completion within 1–3 weeks, depending on assay complexity.

The upgraded service also incorporates rigorous quality control, triplicate assay runs for reproducibility, and strict adherence to radiation safety standards. Each project is supported by experienced technical staff who assist with study design, assay optimization, and data interpretation.

“Our enhanced radioimmunoassay platform delivers both the sensitivity and precision required for today’s demanding research environments,” said Linna, Chief Marketing Staff at Creative BioMart. “By combining customizable assay workflows with stringent quality assurance, we enable our clients to generate reliable, reproducible results even for the most challenging low-abundance targets.”

Creative BioMart’s investment in advancing its RIA services reflects its broader mission to support scientific discovery through high-quality, application-driven solutions. The upgraded platform is designed to accelerate biomarker research, improve analytical confidence, and provide flexible options for both academic and industry clients.

For more information, please visit: https://www.creativebiomart.net/radioimmunoassay.htm.